Live from the NIH registry
Studies recruiting near Asheville right now
Top 25 of 120 recruiting studies, sorted by proximity — each links to its official registry page
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Mission Hospital — Asheville, North Carolina (2.1 mi)
· Sponsor: National Cancer Institute (NCI)
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Ganglioneuroblastoma, Nodular, Neuroblastoma
Phase 3
Interventional 478 participants sought
Mission Hospital — Asheville, North Carolina (2.1 mi)
· Sponsor: National Cancer Institute (NCI)
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
N/A
Interventional 400 participants sought
Pardee BlueMD Endocrinology — Arden, North Carolina (7.5 mi)
· Sponsor: Medtronic MiniMed, Inc.
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Mission Hospital — Asheville, North Carolina (2.1 mi)
· Sponsor: SWOG Cancer Research Network
His-Bundle Corrective Pacing in Heart Failure
Right Bundle-Branch Block, Heart Failure
N/A
Interventional 120 participants sought
Mission Health — Asheville, North Carolina (2.1 mi)
· Sponsor: University of Rochester
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Percutaneous Coronary Intervention, Peripheral Endovascular Intervention
Phase 4
Interventional 6,000 participants sought
Asheville Cardiology Associates Research Department — Asheville, North Carolina (2.1 mi)
· Sponsor: Duke University
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia
Phase 3
Interventional 466 participants sought
Margaret R Pardee Memorial Hospital — Hendersonville, North Carolina (18.2 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients
Non Small Cell Lung Cancer, Epidermal Growth Factor Receptor Gene Mutation
N/A
Observational 538 participants sought
UNC Pardee Cancer Center — Hendersonville, North Carolina (18.2 mi)
· Sponsor: PrECOG, LLC.
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
Geographic Atrophy, Macular Degeneration
Phase 2
Interventional 274 participants sought
Asheville Eye Associates - Western Carolina Retinal Associates — Asheville, North Carolina (2.1 mi)
· Sponsor: Janssen Research & Development, LLC
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Anaplastic Kidney Wilms Tumor, Recurrent Kidney Wilms Tumor
Phase 2
Interventional 256 participants sought
Mission Hospital — Asheville, North Carolina (2.1 mi)
· Sponsor: Children's Oncology Group
ZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castration-Resistant Prostate Cancer
Metastatic Castration-Resistant Prostate Cancer
Phase 2
Interventional 200 participants sought
Messino Cancer Center — Asheville, North Carolina (2.1 mi)
· Sponsor: Zenith Epigenetics
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
Cardiology Associates_Asheville — Asheville, North Carolina (2.1 mi)
· Sponsor: Novo Nordisk A/S
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Stage III Colon Cancer
Phase 2, Phase 3
Interventional 1,912 participants sought
Margaret R Pardee Memorial Hospital — Hendersonville, North Carolina (18.2 mi)
· Sponsor: NRG Oncology
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
Multiple conditions
Phase 3
Interventional 158 participants sought
Margaret R Pardee Memorial Hospital — Hendersonville, North Carolina (18.2 mi)
· Sponsor: National Cancer Institute (NCI)
SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
Type 1 Diabetes
Phase 2
Interventional 159 participants sought
Asheville Clinical Research — Asheville, North Carolina (2.1 mi)
· Sponsor: SAb Biotherapeutics, Inc.
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
Hypertension, Hypertension, Systolic
N/A
Interventional 500 participants sought
HCA Asheville Cardiology Associates — Asheville, North Carolina (2.1 mi)
· Sponsor: Orchestra BioMed, Inc
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
Ulcerative Colitis
Phase 4
Interventional 65 participants sought
Digestive Health Partners — Asheville, North Carolina (2.1 mi)
· Sponsor: Takeda
Mobile Health for Adherence in Breast Cancer Patients
Anatomic Stage IV Breast Cancer AJCC v8, Breast Carcinoma
N/A
Interventional 410 participants sought
Margaret R Pardee Memorial Hospital — Hendersonville, North Carolina (18.2 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
The Treatment of Painful Diabetic Neuropathy With Diet
Painful Diabetic Neuropathy (PDN), Peripheral Neuropathy With Type 2 Diabetes
N/A
Interventional 40 participants sought
AdventHealth Hendersonville — Hendersonville, North Carolina (18.2 mi)
· Sponsor: AdventHealth
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
Phase 1, Phase 2
Interventional 960 participants sought
Mission Hospital — Asheville, North Carolina (2.1 mi)
· Sponsor: PedAL BCU, LLC
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Non Small Cell Lung Cancer
Phase 3
Interventional 768 participants sought
AdventHealth Hendersonville /ID# 265349 — Hendersonville, North Carolina (18.2 mi)
· Sponsor: AbbVie
ERP to Improve Functioning in Veterans With OCD
Obsessive Compulsive Disorder (OCD), Comorbid Post-Traumatic Stress Disorder and OCD
N/A
Interventional 160 participants sought
Asheville VA Medical Center, Asheville, NC — Asheville, North Carolina (2.1 mi)
· Sponsor: VA Office of Research and Development
The ArtixASCEND Study
Acute Lower Limb Arterial Occlusion
N/A
Interventional 250 participants sought
Mission Memorial Hospital — Asheville, North Carolina (2.1 mi)
· Sponsor: Inari Medical
A Global Study Comparing Pulsed Field Ablation With Electrographic Flow Mapping Versus Posterior Wall Ablation for Persistent Atrial Fibrillation
Atrial Fibrillation (AF), Persistant Atrial Fibrillation
N/A
Interventional 699 participants sought
Mission Hospital — Asheville, North Carolina (2.1 mi)
· Sponsor: Boston Scientific Corporation
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Phase 3
Interventional 1,524 participants sought
Margaret R Pardee Memorial Hospital — Hendersonville, North Carolina (18.2 mi)
· Sponsor: Alliance for Clinical Trials in Oncology